Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial

Melatonin may benefit diabetic people with coronary heart disease (CHD) through its beneficial effects on biomarkers of oxidative stress and cardio-metabolic risk. This investigation evaluated the effects of melatonin administration on metabolic status in diabetic patients with CHD.

Gespeichert in:
Autor*in:

Raygan, Fariba [verfasserIn]

Ostadmohammadi, Vahidreza

Bahmani, Fereshteh

Reiter, Russel J.

Asemi, Zatollah

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2019

Schlagwörter:

Oxidative stress

Melatonin supplementation

Metabolic status

Inflammation

Type 2 diabetes mellitus

Coronary heart disease

Umfang:

6

Übergeordnetes Werk:

Enthalten in: Tip Avalanche Photodiode—A spherical-junction SiPM concept - Vinogradov, S. ELSEVIER, 2022, the official journal of the European Society of Parenteral & Enteral Nutrition, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:38 ; year:2019 ; number:1 ; pages:191-196 ; extent:6

Links:

Volltext

DOI / URN:

10.1016/j.clnu.2017.12.004

Katalog-ID:

ELV045705380

Nicht das Richtige dabei?

Schreiben Sie uns!